An observational study in Spondylolisthesis, Lumbar Region, Spinal Trauma With Neurological Deficit and Degeneration of Lumbar Intervertebral Disc, sponsored by University of Pittsburgh. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-10.
Sponsored by University of Pittsburgh · Observational
Investigator left University of Pittsburgh
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 102 studies in Spondylolisthesis with a site in United States — 14 open to participants now, 18 under way, none of them phase 3. Spondylolisthesis · United States.
Among the 102 studies in Spondylolisthesis with a site in United States, this one is the 34th largest by enrollment of the 38 observational ones that give a count, is one of 5 that started in 2024, is one of 38 observational ones, and was the 99th registered.
227 studies on the registry are indexed under Spondylolisthesis; 43 are open to participants now.
Browse Spondylolisthesis studies →14 of the 102 studies in Spondylolisthesis with a site in United States are open now. Recruiting first, the newest first:
Stanford University · Sites in United States
Ages 12–18
Spinal Simplicity LLC · Sites in United States
Ages 18+
Alphatec Spine, Inc. · Sites in United States
Ages 18+
Bioventus LLC · Sites in United States
Ages 21–80
Francis Farhadi · Sites in United States
Ages 18–100
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 27 Spondylolisthesis studies recruiting now, 11 (41%) set no upper age limit and 8 (30%) stop at 75 or younger; 7 take children under 18; 3 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
102 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 6 · Phase 3 5 · Phase 4 8
First in 2000; this study’s year is marked. 5 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 18 is below the median of 108 across 79 observational studies indexed under Spondylolisthesis.
Median enrollment 50 across the 64 interventional studies, 114 across the 38 observational. Of the 67 that completed or were terminated, 20 (30%) have results posted.
This tab as a report to print or save as PDF → With an account.
57 of 102 have an industry lead sponsor. The 10 most frequent:
University of Pittsburgh is the lead sponsor of 1,422 studies on the registry; 170 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 4 (44%) have results posted.
University of Pittsburgh has 1 study filed under Spondylolisthesis — fewer than ten, so there is no comparison to draw.
6 of the studies in Spondylolisthesis with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05691062Twin Cities Spine CenterTitanium vs. PEEK Fusion Devices in 1 Level TLIF | 2027-01-11 |
| NCT05029726John O'TooleRegional Anesthesia in Minimally Invasive Lumbar Spine Surgery | 2027-02-01 |
| NCT06093477Stanford UniversityStudying Melatonin and Recovery in Teens | 2027-06-01 |
| NCT04204135Rush University Medical CenterThe Course of Hip Flexion Weakness Following LLIF or ALIF | 2027-09-04 |
| NCT07766824National University of Natural MedicineEvaluation of an Online Peri-operative Health Education Platform for Patients Undergoing Spine Surgery: Ready Set Recover | 2027-09-30 |
Add all 6 to your calendar (.ics) → With an account.
Among the 102 studies in Spondylolisthesis with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The Viper Prime/Expedium spine systems are intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of acute and chronic instabilities or deformities of the thoracolumbar and sacral spine. The Fibergraft Bioactive Glass (BG) is engineered to mimic the body's natural bone healing process. While previous studies have compared the use of Viper prime/Expedium spine system in minimally invasive and open surgeries, these studies did not specifically study the clinical and radiographic outcomes of patients who have received these implants in addition to Fibergraft. We aim to recruit patients with degenerative disc disease, spondylolisthesis, trauma, and/or pseudarthrosis who require spine surgery under standard of care and use these implants. We will then follow these patients for a duration of two years to report their clinical and radiographic outcomes to determine fusion, complication rate, and revision surgeries if any.
Adult patients with spinal conditions mentioned in inclusion/exclusion criteria
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients who require spine surgery under standard of care and meet the inclusion and exclusion criteria identified, will be recruited from clinic. Consent for participation in study will be signed at the same time as consent for surgery. All PROMs and scans will be done as standard of care and data will be obtained through chart review for this study.
Fusion
We will assess fusion with regular x-rays and CT scans at 1 and 2-year postoperatively.
Time frame: 2 years (At baseline, postoperatively at 6 weeks, 3 months, 6 months, 12 months, and 24 months)
Visual Analog Scale (VAS)
We will have patients fill out validated tools for PROs to assess how the patient is doing postoperatively
Time frame: 2 years (At baseline, postoperatively at 6 weeks, 3 months, 6 months, 12 months, and 24 months)
Oswestry Disability Index (ODI)
We will have patients fill out validated tools for PROs to assess how the patient is doing postoperatively
Time frame: 2 years (At baseline, postoperatively at 6 weeks, 3 months, 6 months, 12 months, and 24 months)
Short form survey-12
We will have patients fill out validated tools for PROs to assess how the patient is doing postoperatively
Time frame: 2 years (At baseline, postoperatively at 6 weeks, 3 months, 6 months, 12 months, and 24 months)
Plan to share: No
No publications or documents are linked to this record.
Ran from Dec 2024 to primary completion in May 2026, 16 months.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: primary completion Dec 2028 → May 2026 and completion Mar 2029 → May 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
Investigator left University of Pittsburgh
Investigator left University of Pittsburgh
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is terminated, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.